Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-31

Clinical Trial Update: Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients [NA]

View source ↗

Summary

This clinical trial is evaluating longitudinal quantitative neuromuscular MRI in patients with neuropathies and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assistance Publique Hopitaux De Marseille | Conditions: Charcot-Marie-Tooth Neuropathy Type 1A, Hereditary Transthyretin Amyloid Neuropathy | NA | Status: RECRUITING